Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth NAV today
AMFI: 148555ISIN: INF754K01LV5MUTF_IN: EDEL_MSCI_INDI_1ONYLLUEdelweiss Mutual FundIndex funds
NAV ₹24.9619up ₹0.35 (1.42%)
NAV for 29 Oct 2026, against 28 Oct 2026. Declared once a day.
Other plans: Direct IDCW ₹22.0173 · Regular Growth ₹24.1273, 1.41% · Regular IDCW ₹21.1861
- Fund sizeAssets under management. The money the fund manages for all its investors, across every plan, at the end of the month. Assets under management in the glossary
- ₹192 CrSep 2026
- Expense ratioTotal expense ratio. What the fund charges each year as a share of the money invested, taken out of the NAV every day, so the returns shown are already after it. Total expense ratio: how it is worked out
- 0.55%25 Oct 2026
- Exit loadExit load. A charge, as a share of the amount redeemed, on units sold before a set period has passed since they were bought. Exit load in the glossary
- None
- P/EP/E. What the fund pays for each rupee of yearly profit its companies earn: the total value of its shares divided by those companies' last four quarters of profit, each in proportion to what the fund holds. The profit leaves out one-off items (exceptional items and businesses sold or demerged), so one company's one-off gain cannot pull the fund's P/E down. A loss-making company lowers the profit. Shown when at least 80% of the fund's shares are counted. P/E in the glossary
- 39.530 Sep 2026
- Risk levelRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month. Riskometer in the glossary
- Very HighAug 2026
- HoldingsHoldings. The number of different securities in the fund's latest monthly portfolio: shares, bonds, money market paper and units of other funds, not cash, overnight lending or futures. Holdings in the glossary
- 4530 Sep 2026
- LaunchedLaunch date. The day the fund first allotted units to investors, at the close of its new fund offer. Launch date in the glossary
- 26 Oct 2020
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund returns
Direct Growth plan
Over each window to 29 Oct 2026
| Over | Direct GrowthTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). Trailing return: how it is worked out | Regular Growth | BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back. Benchmark in the glossary |
|---|---|---|---|
| 1 week | +4.09% | +4.07% | – |
| 1 month | +0.39% | +0.35% | – |
| 3 months | +0.72% | +0.58% | – |
| 6 months | +16.41% | +16.09% | – |
| 1 year | +19.24% | +18.59% | +21.32%to 30 Sep 2026 |
| 3 years | +21.78% | +21.12% | +19.28%to 30 Sep 2026 |
| 5 years | +14.79% | +14.15% | +14.28%to 30 Sep 2026 |
| 10 years | Needs 10 years | – | – |
₹10,000 put in on 2 Nov 2020 is ₹24,981 at the NAV of 29 Oct 2026Growth of ₹10,000. What ₹10,000 put in at the NAV of the first day would be worth at the latest NAV, after the fund's expenses and before tax and any exit load. Growth of ₹10,000 in the glossaryOver a year and longer, a return is the yearly rate. Benchmark: MSCI India Domestic & World Healthcare 45 Index, over the same days as the fund, or to the month end its cell names.
At the month end, 30 Sep 2026
| Over | Fund | BenchmarkBenchmark return. The change in the benchmark index's total return level over the same dates as the fund's return, as a yearly rate over a year and longer. Benchmark return in the glossary |
|---|---|---|
| 1 year | +20.97% | +21.32% |
| 3 years | +18.79% | +19.28% |
| 5 years | +13.87% | +14.28% |
| Since launch | +16.15% | +16.47% |
Benchmark: MSCI India Domestic & World Healthcare 45 Index. Both as the fund house states them for the month.
Return in each calendar year
- Fund, Direct GrowthCalendar year return. The change in NAV from the last NAV of one year to the last NAV of the next.
- Loss
Highest year to Dec 2024, +29.6%; lowest year to Dec 2022, −4.8%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund SIP returns
₹10,000 on the 1st of every month, valued at the NAV of 29 Oct 2026SIP calculator
| Period | InvestedAmount invested. ₹10,000 on the 1st of every month, or the next day the fund priced, added up over the period. Amount invested in the glossary | Value todayValue today. What the units bought by every instalment are worth at the latest NAV. Value today in the glossary | Invested against value today | SIP returnSIP return (XIRR). The yearly rate that, applied to each monthly instalment from the day it was invested, gives the value of all the units today. SIP return (XIRR) in the glossary | After stamp dutySIP return after stamp duty. The same SIP return with stamp duty of 0.005% taken from every instalment since 1 Jul 2020, so ₹10,000 buys ₹9,999.50 of units. SIP return after stamp duty in the glossary | Stamp dutyStamp duty paid. The stamp duty on all the instalments, in rupees: 0.005% of each purchase made since 1 Jul 2020. Stamp duty paid in the glossary |
|---|---|---|---|---|---|---|
| 1 year12 instalments | ₹1,20,000 | ₹1,34,036₹1,34,030 after stamp duty | +22.68% | +22.66% | ₹6 | |
| 3 years36 instalments | ₹3,60,000 | ₹4,58,246₹4,58,223 after stamp duty | +16.39% | +16.38% | ₹18 | |
| 5 years60 instalments | ₹6,00,000 | ₹9,35,570₹9,35,523 after stamp duty | +17.85% | +17.85% | ₹30 | |
| Since Nov 202071 instalments | ₹7,10,000 | ₹11,70,255₹11,70,197 after stamp duty | +16.80% | +16.80% | ₹36 |
10 years: Launched 26 Oct 2020, needs 10 years of history.
A SIP that rises every year: Step-up SIP calculator
Rolling returns
Per cent a year, every window from 2 Nov 2020 to 29 Oct 2026
Lowest to highestAverage
LowestLowest rolling return. The lowest yearly return of any window of this length in the fund's history, one window starting on each day it priced. Lowest rolling return in the glossaryAverageAverage rolling return. The average of the yearly returns of every window of this length in the fund's history. Average rolling return in the glossaryHighestHighest rolling return. The highest yearly return of any window of this length in the fund's history. Highest rolling return in the glossaryEnded higherWindows that ended higher. The share of all the windows of this length in which the NAV ended above where it started. Windows that ended higher in the glossary
1 year1,189 windows−10.4%+14.9%+49.7%80.9%
3 years713 windows+11.0%+17.5%+23.7%100.0%
5 yearsLaunched 26 Oct 2020, needs 6 years of history
Every 3-year window ended higher than it started.
Tracking error
Against MSCI India Domestic & World Healthcare 45 Index, as on 30 Sep 2026.
Against its index, by window
| Measure | Direct, this plan | Regular |
|---|---|---|
| Tracking errorTracking error. How much an index fund's daily returns differed from its index's, stated as a yearly figure. Tracking error in the glossary | 1.22% | 1.22% |
| Difference, 1 yearTracking difference. The index fund's return less its index's return over the same period; the fund's costs make it negative. Tracking difference in the glossary | −0.35 pts | −1.00 pts |
| Difference, 3 years | −0.50 pts | −1.14 pts |
| Difference, 5 years | −0.41 pts | −1.04 pts |
| Difference since launch | −0.32 pts | −0.98 pts |
Difference: the fund's return less the index's, in percentage points.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund expense ratio and exit load
Per cent of the money invested, a year. Each month shows its last day filed; the parts were redefined from Apr 2026.
- Regular over directDirect and regular plan cost gap. The regular plan's expense ratio less the direct plan's: what buying through a distributor costs each year, since both plans own the same portfolio. Direct and regular plan cost gap in the glossary
- 0.55 ptsA year, on 25 Oct 2026
- Direct, 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies. Expense ratio, 30-day average in the glossary
- 0.55%Over the last 30 days filed
- Regular, 30-day average
- 1.10%Over the last 30 days filed
Total expense ratio, month by month
- Regular plan
- Direct plan
Direct plan highest 0.56%, Aug 2026.Direct plan lowest 0.38%, Mar 2021.
What the expense ratio is made of
| Part | Direct | Regular |
|---|---|---|
| Base expense ratioBase expense ratio. The part of the expense ratio that pays the fund house and the distributor, before brokerage, transaction costs, levies and GST. Base expense ratio in the glossary | 0.43% | 0.90% |
| Brokerage | 0.01% | 0.01% |
| Transaction costs | None | None |
| Statutory levies | 0.11% | 0.19% |
Per cent of assets a year, filed for 25 Oct 2026. The parts add up to that day's total.
Buying and selling
- Lump-sum purchases
- Accepted
- Minimum investmentMinimum investment. The smallest amount the plan accepts for a first purchase. Minimum investment in the glossary
- ₹100
- Minimum top-up
- ₹100
- Minimum redemption
- ₹1
- SIP
- Accepted
- SIP minimum
- M - 100
- SIP instalments, at least
- M - 6
- STP, transfers to another fund
- Not accepted
- SWP, regular withdrawals
- Accepted
- Switches
- Accepted
- Lock-inLock-in. The time after each purchase during which those units cannot be sold. Lock-in in the glossary
- None
- SIP dates
- M - 01,02,03,04,05,06,07,08,09,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27
As listed for this plan on 31 Oct 2026.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund AUM
₹ crore, every plan of the fund together.
- Average assetsAverage assets under management. The money the fund managed, averaged over every day of the quarter, added up across its plans.
- ₹195 CrQuarter to Sep 2026
- In the direct plansShare of assets in the direct plans. The direct plans' average assets for the quarter as a percentage of the fund's total; the rest is in the regular plans, bought through distributors. Share of assets in the direct plans in the glossary
- 39.5%Of the quarter's average
Average assets by quarter, by plan
- Regular plans
- Direct plans
The latest quarter is the largest since the quarter to Dec 2020.
Assets at each month end
Highest ₹200 Cr, Aug 2026.Lowest ₹124 Cr, Oct 2023.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund portfolio
Portfolio disclosed for 30 Sep 2026.
Holdings on 30 Sep 2026
| Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month. Large, mid and small cap in the glossary | Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. Weight in the fund in the glossary | Held since. The first month end of the fund's current run of holding this position; marked "or earlier" where that month is the fund's first portfolio on record or the first after a gap in its portfolios. Held since in the glossary | ||||
|---|---|---|---|---|---|---|
| Sun Pharmaceutical IndustriesPharmaceuticals & Biotechnology | Shares | Large cap13th | 10.45% | 20.04 | 1,10,321 | Nov 2020 |
| Divi's LaboratoriesPharmaceuticals & Biotechnology | Shares | Large cap50th | 7.09% | 13.61 | 14,648 | Nov 2020 |
| ELI LILLY & COPharmaceuticals | Foreign shares | 6.46% | 12.39 | 1,116 | Jun 2022 | |
| Apollo Hospitals EnterpriseHealthcare Services | Shares | Large cap97th | 5.25% | 10.08 | 12,342 | Nov 2020 |
| JOHNSON & JOHNSONPharmaceuticals | Foreign shares | 4.45% | 8.53 | 3,356 | Oct 2020or earlier | |
| Laurus LabsPharmaceuticals & Biotechnology | Shares | Mid cap171st | 4.44% | 8.52 | 43,046 | Nov 2020 |
| Torrent PharmaceuticalsPharmaceuticals & Biotechnology | Shares | Large cap61st | 4.38% | 8.39 | 17,489 | Nov 2020 |
| CiplaPharmaceuticals & Biotechnology | Shares | Large cap99th | 4.34% | 8.33 | 61,907 | Nov 2020 |
| Max Healthcare InstituteHealthcare Services | Shares | Mid cap111th | 4.19% | 8.04 | 86,518 | Jul 2021 |
| Dr. Reddy's LaboratoriesPharmaceuticals & Biotechnology | Shares | Mid cap104th | 3.95% | 7.57 | 61,404 | Nov 2020 |
| ABBVIE INCBiotechnology | Foreign shares | 3.22% | 6.18 | 2,463 | Oct 2020or earlier | |
| LupinPharmaceuticals & Biotechnology | Shares | Mid cap105th | 2.97% | 5.69 | 28,031 | Nov 2020 |
| Aurobindo PharmaPharmaceuticals & Biotechnology | Shares | Mid cap138th | 2.77% | 5.31 | 31,758 | Nov 2020 |
| MERCK & CO.INCPharmaceuticals | Foreign shares | 2.50% | 4.80 | 3,444 | Oct 2020or earlier | |
| Fortis HealthcareHealthcare Services | Shares | Mid cap156th | 2.41% | 4.63 | 60,170 | Nov 2020 |
Weight is per cent of the fund's net assets; value in ₹ crore.
Cash and receivables on 30 Sep 2026
| Clearing Corporation of India Ltd. | 0.10% | 0.20 |
| Net Receivables/(Payables) | −0.01% | −0.07 |
| Accrued Interest | 0.00% | 0.00 |
Weight is per cent of the fund's net assets; value in ₹ crore.
- Largest holdingLargest holding. The share of the fund in its single largest position, cash and futures not counted as positions. Largest holding in the glossary
- 10.45%Sun Pharmaceutical Industries
- Top 5 holdingsTop 5 holdings. The share of the fund held in its five largest positions. Top 5 holdings in the glossary
- 33.70%
- Top 10 holdingsTop 10 holdings. The share of the fund held in its ten largest positions. Top 10 holdings in the glossary
- 55.00%
- Top 10 sharesTop 10 shares. The share of the fund held in its ten largest shareholdings, bonds and fund units left out. Top 10 shares in the glossary
- 49.83%
- Effective holdingsEffective number of holdings. The number of equal-sized positions that would be as concentrated as the fund's actual weights. Effective number of holdings in the glossary
- 23.9Taken over 99.91% of the fund
Asset allocation
Asset allocation. What the fund owns, by kind of asset, each as a share of its net assets; futures and options are shown beside it, not in it, since they are contracts rather than assets bought. Asset allocation in the glossary- Indian shares68.60%
- Foreign shares31.31%
- Cash and receivables0.09%
Per cent of the fund's net assets.
Large, mid and small cap
- Large cap45.93%
- Mid cap50.15%
- Small cap3.92%
Per cent of the fund's Indian shares. By the list for the six months to Jun 2026.
Sector allocation
Sector weight. The fund's shares grouped by the business each company is in, less the futures sold on them, each group as a share of the fund's net assets. Sector weight in the glossary1sector
- Healthcare68.60%
- Foreign shares31.31%
Per cent of the fund's net assets, less the futures sold on its shares, Sep 2026. Foreign shares are one part, not split by sector.
Sector allocation month by month
| 13 months | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare25 companies | 68.60% | 68.83% | 69.55% | 69.30% | 70.63% | 70.78% | 69.03% | 69.11% | 68.00% | 66.35% | 66.83% | 68.62% | |
| Foreign sharesPharmaceuticals, Biotechnology, Life Sciences Tools & Services, Health Care Equipment & Supplies, Pharmaceuticals & Biotechnology | 31.31% | 31.06% | 30.27% | 30.48% | 29.04% | 28.94% | 30.47% | 30.57% | 31.82% | 33.59% | 33.06% | 31.23% |
Per cent of the fund's net assets, less the futures sold on its shares, at each month end, Oct 2025 to Sep 2026; the line runs from Sep 2025.
Bought and sold
Sep 2026 against Aug 2026, position by position.
Positions changed, month by month
- New
- Added
- Trimmed
- Sold out
- New positionsNew positions. Holdings in this month's portfolio that were not in the month before. New positions in the glossary
- 10.62% of the fund
- Sold outSold out. Holdings in last month's portfolio that are gone from this one, other than a bond or deposit repaid on its due date. Sold out in the glossary
- 0
- Added toAdded to. Holdings with more units than the month before. Where the fund states no units, a weight that rose by more than a tenth. Added to in the glossary
- 1
- TrimmedTrimmed. Holdings with fewer units than the month before. Where the fund states no units, a weight that fell by more than a tenth. Trimmed in the glossary
- 43
- UnchangedUnchanged. Holdings with the same number of units as the month before. Their weight can still move with the price. Unchanged in the glossary
- 0
- Traded at leastTraded at least. The smaller of the weight bought in new positions and the weight sold out of old ones, cash left out: the least the fund must have bought and sold in the month. Traded at least in the glossary
- 0.00%
- Weight that movedWeight that moved. Half the sum of every position's change in weight between the two month ends, new and sold positions included; price moves alone raise it. Weight that moved in the glossary
- 2.57%
Changes in Sep 2026
| What changed. New: not held the month before. Added or trimmed: more or fewer units than the month before, or, where no units are stated, a weight that moved by more than a tenth. Sold out: held the month before, gone now. Matured: a bond or deposit whose repayment date fell between the two portfolios, so it was repaid rather than sold (one sold in its last days reads the same). What changed in the glossary | Change in weight. The holding's weight this month less its weight the month before, in percentage points; a price move alone changes it. Change in weight in the glossary | ||||
|---|---|---|---|---|---|
| Wockhardt | New | 0.62% | 0.00% | +0.62 pts | +5,580 |
| Sun Pharmaceutical Industries | Trimmed | 10.45% | 10.99% | −0.54 pts | −198 |
| Dr. Reddy's Laboratories | Trimmed | 3.95% | 3.56% | +0.39 pts | −109 |
| Fortis Healthcare | Trimmed | 2.41% | 2.74% | −0.33 pts | −108 |
| Max Healthcare Institute | Trimmed | 4.19% | 4.52% | −0.33 pts | −151 |
| Laurus Labs | Trimmed | 4.44% | 4.14% | +0.30 pts | −58 |
| Apollo Hospitals Enterprise | Trimmed | 5.25% | 5.51% | −0.26 pts | −21 |
| THERMO FISHER SCIENTIFIC INC | Trimmed | 1.75% | 1.57% | +0.18 pts | −13 |
| Biocon | Trimmed | 1.47% | 1.64% | −0.17 pts | −3,238 |
| Novo Nordisk A/S | Trimmed | 0.85% | 1.00% | −0.15 pts | −109 |
| Divi's Laboratories | Trimmed | 7.09% | 6.96% | +0.13 pts | −26 |
| ABBVIE INC | Trimmed | 3.22% | 3.10% | +0.12 pts | −63 |
| ELI LILLY & CO | Trimmed | 6.46% | 6.34% | +0.12 pts | −31 |
| ABBOTT LABORATORIES | Trimmed | 1.20% | 1.31% | −0.11 pts | −58 |
| Lupin | Trimmed | 2.97% | 3.08% | −0.11 pts | −48 |
Weights are per cent of the fund's net assets; a change in weight is in percentage points.
Holdings month by month
| Holding | Oct 25 | Nov 25 | Dec 25 | Jan 26 | Feb 26 | Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Sun Pharmaceutical Industries | 11.16%Cut | 11.50%Cut | 10.98%Cut | 10.90%Added | 11.25%Cut | 11.73%Cut | 11.90%Added | 11.42%Added | 10.96%Cut | 11.30%Cut | 10.99%Cut | 10.45%Cut |
 Divi's Laboratories | 5.54%Cut | 5.06%Cut | 5.08%Cut | 5.15%Added | 5.17%Cut | 5.08%Added | 5.33%Cut | 5.27%Added | 5.14%Added | 6.07%Cut | 6.96%Cut | 7.09%Cut |
| ELI LILLY & CO | 5.75% | 6.83%Cut | 6.97%Cut | 6.27%Cut | 6.01% | 5.72% | 5.70% | 6.50% | 6.85%Added | 6.43%Added | 6.34% | 6.46%Cut |
 Apollo Hospitals Enterprise | 5.32%Cut | 5.18%Added | 5.05%Cut | 5.35%Added | 5.69%Cut | 5.59%Cut | 5.65%Added | 5.83%Added | 5.71%Cut | 5.69%Cut | 5.51%Cut | 5.25%Cut |
| JOHNSON & JOHNSON | 3.75% | 3.93%Cut | 4.02%Cut | 4.12%Cut | 4.25% | 4.52%Cut | 4.17% | 3.94% | 4.35%Added | 4.30%Added | 4.37% | 4.45%Cut |
 Laurus Labs | 2.30%Cut | 2.37%Cut | 2.59%Cut | 2.41%Added | 2.55%Cut | 2.44%Cut | 2.65%Added | 3.16%Added | 3.48%Added | 4.02%Cut | 4.14%Cut | 4.44%Cut |
 Torrent Pharmaceuticals | 2.90%Cut | 2.88%Cut | 3.03%Cut | 3.34%Added | 3.46%Cut | 3.55%Added | 3.40%Cut | 3.46%Added | 3.07%Cut | 4.61%Added | 4.45%Cut | 4.38%Cut |
 Cipla | 5.84%Cut | 5.66%Cut | 5.69%Cut | 5.33%Added | 5.14%Cut | 4.84%Cut | 5.08%Added | 5.24%Added | 4.84%Cut | 4.69%Cut | 4.38%Cut | 4.34%Cut |
 Max Healthcare Institute | 6.14%Cut | 5.92%Cut | 5.41%Cut | 5.30%Added | 5.73%Cut | 5.30%Added | 5.30%Cut | 4.97%Added | 5.21%Cut | 4.89%Cut | 4.52%Cut | 4.19%Cut |
 Dr. Reddy's Laboratories | 4.81%Cut | 4.47%Cut | 4.59%Cut | 4.71%Added | 4.71%Cut | 4.76%Cut | 4.92%Added | 4.68%Added | 4.44%Cut | 3.63%Cut | 3.56%Cut | 3.95%Cut |
| ABBVIE INC | 3.18% | 3.17%Cut | 3.25%Cut | 2.96%Cut | 2.91% | 2.95%Cut | 2.81% | 2.79% | 3.16%Added | 3.09%Added | 3.10% | 3.22%Cut |
 Lupin | 3.08%Cut | 3.42%Added | 3.53%Cut | 3.85%Added | 3.90%Cut | 4.13%Added | 3.97%Cut | 3.77%Added | 3.62%Cut | 3.48%Cut | 3.08%Cut | 2.97%Cut |
 Aurobindo Pharma | 2.05%Cut | 2.10%Cut | 2.06%Cut | 2.25%Added | 2.15%Cut | 2.37%Cut | 2.49%Added | 2.47%Added | 2.70%Added | 2.61%Cut | 2.76%Cut | 2.77%Cut |
| MERCK & CO.INC | 1.78% | 2.07%Cut | 2.12%Cut | 2.07%Cut | 2.20% | 2.29%Cut | 2.04% | 2.14% | 2.26%Added | 2.24%Added | 2.49% | 2.50%Cut |
 Fortis Healthcare | 3.45%Cut | 2.95%Cut | 2.89%Cut | 2.98%Added | 3.12%Cut | 2.77%Added | 3.11%Cut | 3.01%Added | 3.07%Added | 2.93%Cut | 2.74%Cut | 2.41%Cut |
Per cent of the fund's net assets at each month end, Oct 2025 to Sep 2026. Under it, the change on the fund's previous month. "After a gap" is a holding after a month with no portfolio on record, so when it was bought is not known; "Not filed" is one gone across such a gap.
Portfolio turnover, per cent of assets a year
- TurnoverPortfolio turnover. How much of the portfolio the fund bought or sold over the last year, as a share of its assets, as the fund house states it. Portfolio turnover in the glossary
Highest 19.9% in Apr 2025
Risk ratios
NAV to 29 Oct 2026
How much the NAV moves
Standard deviationStandard deviation. How far the fund's monthly returns spread around their average, stated as a yearly figure: the wider the spread, the more the NAV moves. Standard deviation in the glossary12.54%
Downside deviationDownside deviation. Standard deviation counting only the months in which the fund lost money, stated as a yearly figure. Downside deviation in the glossary5.92%
Sharpe ratioSharpe ratio. The monthly return above the 91-day Treasury bill yield, divided by its standard deviation and stated for a year: the extra return for each unit of movement in the NAV. Sharpe ratio in the glossary0.98
Sortino ratioSortino ratio. The monthly return above the 91-day Treasury bill yield, divided by how far it fell below that yield and stated for a year: the extra return for each unit of movement on the way down. Sortino ratio in the glossary1.78
Largest falls
| Largest over | FallLargest fall. The biggest drop in NAV from a high to the low that followed, before the NAV went back above that high. Largest fall in the glossary | High on | Low on | Back at the highBack at the high. The first day the NAV closed at or above the high it had fallen from. Back at the high in the glossary |
|---|---|---|---|---|
| 1 year | −6.64% | 26 Feb 2026 | 6 Apr 2026 | 14 May 2026 |
| 3 years | −12.15% | 9 Oct 2024 | 7 Apr 2025 | 17 Oct 2025 |
| 5 years | −16.14% | 31 Dec 2021 | 17 Jun 2022 | 15 Jun 2023 |
| Since Nov 2020 | −16.31% | 3 Sep 2021 | 17 Jun 2022 | 15 Jun 2023 |
Risk level by month
| Months | Fund | BenchmarkBenchmark's risk level. The riskometer level of the fund's benchmark index for the same month, on the same six-step scale as the fund's own. Benchmark's risk level in the glossary |
|---|---|---|
| Mar 2025 to Aug 202618 months | Very High | Very HighMSCI India Domestic & World Healthcare 45 Index |
| Feb 20251 month | Very High | MSCI India Domestic & World Healthcare 45 Index |
| Sep 2021 to Jan 202541 months | Very High | Very HighMSCI India Domestic & World Healthcare 45 Index |
The riskometer at each month end, the fund's and its benchmark's. A month with none on record is left out.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund managers
Managers now
| Manager | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. Return in the manager's time in the glossary | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. Benchmark over the same days in the glossary | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. Difference from the benchmark in the glossary | Portfolio changed after the handover. How much of the portfolio was different three months after the manager took over: half the sum of every holding's change in weight, with each side's holdings scaled to add up to 100 so a move into cash does not count. Portfolio changed after the handover in the glossary | Portfolio changed before the handover. The same measure over the three months before the manager took over, since portfolios change anyway. Portfolio changed before the handover in the glossary | Assets the manager runs. The latest monthly size of every fund the manager runs now, added up; a fund run with others counts in full for each of its managers, and the line under it counts only the funds they run alone. Assets the manager runs in the glossary | ||
|---|---|---|---|---|---|---|---|---|
| Bhavesh Jain | Oct 2021 | +13.03%a year | – | – | 4.9% | 6.7% | 40 | ₹56,394 Cr₹7.87 Cr alone |
| Manasi JalgaonkarAssistant Fund Manager | Apr 2026 | +13.22%over 205 days | – | – | 5.1% | 6.9% | 19 | ₹4,213 Cr |
| Amit Vorafor investments in foreign securities | Dec 2021 | +13.73%a year | – | – | 8.5% | 4.5% | – | – |
Returns are the direct plan's growth NAV, from the day each took over to the latest NAV, beside the benchmark over the same days.
Other funds they run
| Fund | |||||
|---|---|---|---|---|---|
| Edelweiss Arbitrage FundBhavesh Jain | Jun 2014 | +6.83%a year | +5.93% | +0.91 pts | ₹14,250 Cr |
| Edelweiss Balanced Advantage FundBhavesh Jain | Aug 2013 | +12.19%a year | – | – | ₹12,880 Cr |
| Edelweiss US Technology Equity Fund of FundBhavesh Jain | Mar 2020 | +24.16%a year | – | – | ₹4,547 Cr |
| Edelweiss Aggressive Hybrid FundBhavesh Jain | Oct 2015 | +12.55%a year | – | – | ₹3,875 Cr |
| Edelweiss Gold and Silver ETF FOFBhavesh Jain | Sep 2022 | +31.45%a year | – | – | ₹3,204 Cr |
| Edelweiss Greater China Equity Off-shore FundBhavesh Jain | Sep 2019 | +11.48%a year | – | – | ₹2,996 Cr |
| Edelweiss Multi Asset Allocation FundBhavesh Jain | Jun 2023 | +7.41%a year | – | – | ₹2,961 Cr |
| Edelweiss Arbitrage FundAmit Vora | Nov 2024 | +6.90%a year | +7.39% | −0.49 pts | ₹14,250 Cr |
| Edelweiss Multi Cap FundAmit Vora | Oct 2023 | +14.64%a year | +10.82% | +3.83 pts | ₹3,345 Cr |
| Edelweiss Multi Asset Allocation FundAmit Vora | Jun 2023 | +7.41%a year | – | – | ₹2,961 Cr |
The ten largest by assets, by manager. Returns are the direct plan's.
Portfolio overlap
Funds holding the most of the same securities, by weight.
Closest funds in the category
| Portfolio overlap. The share of the two funds' portfolios that is the same: for every holding they share, the smaller of its two weights, added up. Portfolio overlap in the glossary | Shared holdings. The number of securities both funds hold, cash and futures left out. Shared holdings in the glossary | |
|---|---|---|
| Bandhan BSE Healthcare Index FundBandhan Mutual Fund | 67.71% | 25 |
| DSP Nifty Healthcare Index FundDSP Mutual Fund | 63.31% | 18 |
| ICICI Prudential Nifty Pharma Index FundICICI Prudential Mutual Fund | 53.09% | 17 |
| Motilal Oswal Nifty MidSmall Healthcare Index FundMotilal Oswal Mutual Fund | 27.58% | 17 |
| Tata Nifty MidSmall Healthcare Index FundTata Mutual Fund | 27.58% | 17 |
| Nippon India Nifty 500 Low Volatility 50 Index FundNippon India Mutual Fund | 22.77% | 8 |
| Tata Nifty500 Multicap India Manufacturing 50 30 20 Index FundTata Mutual Fund | 19.95% | 12 |
| Nippon India Nifty India Manufacturing IndexNippon India Mutual Fund | 18.51% | 11 |
| Navi Nifty India Manufacturing Index FundNavi Mutual Fund | 18.47% | 11 |
| Kotak Nifty 100 Low Volatility 30 Index FundKotak Mahindra Mutual Fund | 17.60% | 5 |
Portfolios for Sep 2026. Overlap is per cent of the portfolio the two funds hold in common.
Changes to the fund
Newest first.
2026
- 27 OctTermsSIP instalments: not accepted to accepted
- 24 OctTermsLargest purchase accepted: ₹1,00,000 to not stated
- 24 OctTermsNew purchases: not accepted to accepted
- 1 AprExpenseExpense ratio stated under the new rules: a base ratio, with brokerage, levies and GST on top
Fund details
Objective
The Scheme will invest in stocks comprising of the MSCI India Domestic IMI and World Healthcare Select Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.
Asset allocation
- Stocks comprising the MSCI India Domestic IMI and World Healthcare Select Index - 95-100%
- Debt and Money Market Instruments/ units of Liquid Mutual Fund - 0-5%
Type of scheme
An open ended Equity scheme replicating MSCI India Domestic & World Healthcare 45 Index
- Stated category
- Fund of funds investing overseas
- Benchmark
- MSCI India Domestic & World Healthcare 45 Index
- Risk level at launch
- Very High Risk
- New fund offer
- 6 Oct 2020 to 20 Oct 2020
- Units first allotted
- 26 Oct 2020
- Price at the offer
- ₹10 a unit
- Minimum at the offer
- ₹5,000
Plans and codes
| Plan | AMFI code | ISIN | ISIN, reinvestment | MUTF_IN | First NAV |
|---|---|---|---|---|---|
| Direct Growth | 148555 | INF754K01LV5 | EDEL_MSCI_INDI_1ONYLLU | 2 Nov 2020 | |
| Regular Growth | 148557 | INF754K01LR3 | EDEL_MSCI_INDI_1VRHUCB | 2 Nov 2020 | |
| Direct IDCW | 148556 | INF754K01LW3 | INF754K01LX1 | EDEL_MSCI_INDI_H6056G | 2 Nov 2020 |
| Regular IDCW | 148558 | INF754K01LS1 | INF754K01LT9 | EDEL_MSCI_INDI_WNUJ00 | 2 Nov 2020 |
This fund
- Scheme information documentThe fund's objective, terms, costs and risks in full
Factsheet
- Factsheet - October 2026Edelweiss Mutual Fund, Sep 2026
Statement of additional information
- SAI Edelweiss Mutual FundEdelweiss Mutual Fund, Oct 2026
Annual report
- Edelweiss Mutual Fund - Abridged Annual Report - Equity (2025-26)Edelweiss Mutual Fund, Mar 2026
- Edelweiss Mutual Fund - Abridged Annual Report - Debt (2025-26)Edelweiss Mutual Fund, Mar 2026
- Edelweiss Mutual Fund - Annual Report (2025-26)Edelweiss Mutual Fund, Mar 2026
Riskometer disclosure
- Risk-o-Meter Summary October 09, 2026Edelweiss Mutual Fund, Sep 2026
Portfolio overlap disclosure
- Portfolio Overlap 30-Sep-2026Edelweiss Mutual Fund, Sep 2026